Home
Tality
TM
About
Science
Clinical Trials
News
Contact
TRY TALITY
Latest News
Filtricine Preclinical Results Published
December 22, 2021
Filtricine is pleased to announce that the preclinical research results of its proprietary medical food technology
Read more
Clinical Results Presented at PCF Retreat
November 6, 2021
Filtricine is pleased to announce that researchers leading a Filtricine-sponsored prostate cancer clinical study at Stanford University
Read more
We Are Excited to Announce Filtricine's Latest Round of Investment
August 3, 2021
Filtricine's Seed Round announcement, led by Boutique Venture Partners and Berkeley Catalyst Fund
Read more
Filtricine Appoints a New Chief Executive Officer
December 22, 2020
It is our great pleasure to announce that Dr. John Chant has accepted our offer as Chief Executive Officer.
Read more
Filtricine Initiates the First Clinical Study
July 8, 2020
Filtricine today announced the start of its first human clinical study among prostate cancer patients.
Read more
Filtricine Presents Research at Scientific Conference for Cancer Treatment
November 1, 2019
At the AACR-NCI-EORTC conference for molecular targets (#Targets19) in Boston
Read more
IndieBio Demo Day Presentation
November 6, 2018
We proudly graduated from the phenomenal four-month program at IndieBio.
Read more
View all
